Engineers Gate Manager’s Inovio Pharmaceuticals INO Stock Holding History

Engineers Gate Manager’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,502	Closed	-$24.7K	–	2355
2024 Q4	$24.7K	Buy	+13,502	New	+$59.8K	﹤0.01%	2147
2022 Q1	–	Sell	-5,437	Closed	-$326K	–	2066
2021 Q4	$326K	Buy	+5,437	New	+$436K	0.01%	1346
2021 Q2	–	Sell	-1,217	Closed	-$135K	–	1802
2021 Q1	$135K	Buy	+1,217	New	+$160K	0.01%	1664
2017 Q4	–	Sell	-1,542	Closed	-$117K	–	782
2017 Q3	$117K	Buy	+1,542	New	+$115K	0.01%	663

Other funds holding INO

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Engineers Gate Manager's INO Position: Q1 2025 in Review

Engineers Gate Manager sold out of Inovio Pharmaceuticals (INO) in Q1 2025, closing a stake of 13,502 shares — an estimated $24.7K sold.

Engineers Gate Manager first reported a position in INO in Q3 2017 and held it in 4 quarters. The position peaked at $326K in Q4 2021. 107 funds tracked by Wall St. Rank hold INO as of Q1 2025.

Engineers Gate Manager reported no remaining Inovio Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Engineers Gate Manager sold 13,502 Inovio Pharmaceuticals shares in Q1 2025, an estimated $24.7K.
Engineers Gate Manager first reported a position in Inovio Pharmaceuticals in Q3 2017 and held it in 4 quarters.
Engineers Gate Manager's Inovio Pharmaceuticals position peaked at $326K in Q4 2021.
107 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2025.

Based on Engineers Gate Manager's 13F filing for Q1 2025, filed 15 May 2025.